Abstract
Cardiotoxicity is a well-known adverse effect of anthracyclines and trastuzumab. The roles of statins, beta blockers (BBs), and ACEI/ARBs in the context of anthracycline and trastuzumab use are unsettled, mostly due to variability in study findings. Primary studies on use of statins, BBs, and ACEI/
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.